James C. Czirr's most recent trade in Galectin Therapeutics Inc was a trade of 70,000 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on Feb. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 03 Feb 2025 | 70,000 | 965,541 (1%) | 0% | 2.1 | 147,700 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 70,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 03 Feb 2025 | 46,875 | 800,541 (1%) | 0% | 2.4 | 112,031 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 46,875 | 245,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 40,000 | 0 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 03 Feb 2025 | 40,000 | 895,541 (1%) | 0% | 2.1 | 84,400 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.98 per share. | 03 Feb 2025 | 40,000 | 1,005,541 (1%) | 0% | 2.0 | 79,200 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 03 Feb 2025 | 40,000 | 1,045,541 (1%) | 0% | 1.1 | 44,400 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 40,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.89 per share. | 03 Feb 2025 | 31,250 | 753,666 (1%) | 0% | 0.9 | 27,813 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 31,250 | 291,875 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.86 per share. | 03 Feb 2025 | 30,000 | 855,541 (1%) | 0% | 2.9 | 85,800 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 30,000 | 190,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.72 per share. | 03 Feb 2025 | 25,000 | 825,541 (1%) | 0% | 4.7 | 118,000 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 25,000 | 220,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Feb 2025 | 10,000 | 731,416 (1%) | 0% | - | Common Stock | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Feb 2025 | 10,000 | 721,416 (1%) | 0% | - | Common Stock | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Other type of transaction at price $ 6.00 per share. | 03 Feb 2025 | 1,000 | 722,416 (1%) | 0% | 6 | 6,000 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 5,000 | 741,416 (1%) | 0% | - | Common Stock | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 4,400 | 746,016 (1%) | 0% | - | Common Stock | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 4,400 | 750,416 (1%) | 0% | - | Common Stock | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 4,400 | 754,816 (1%) | 0% | - | Common Stock | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 4,400 | 759,216 (1%) | 0% | - | Common Stock | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Other type of transaction at price $ 6.00 per share. | 31 Dec 2024 | 1,000 | 763,616 (1%) | 0% | 6 | 6,000 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Other type of transaction at price $ 6.00 per share. | 31 Dec 2024 | 1,000 | 747,016 (1%) | 0% | 6 | 6,000 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 600 | 746,416 (1%) | 0% | - | Common Stock | |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.06 per share. | 22 Apr 2024 | 21,323 | 5,925,884 (10%) | 0% | 3.1 | 65,248 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.06 per share. | 22 Apr 2024 | 3,677 | 5,922,207 (10%) | 0% | 3.1 | 11,252 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Other type of transaction at price $ 6.00 per share. | 31 Dec 2023 | 1,000 | 762,616 (1%) | 0% | 6 | 6,000 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Ten Percent Owner | Other type of transaction at price $ 6.00 per share. | 31 Dec 2023 | 1,000 | 761,616 (1%) | 0% | 6 | 6,000 | Common Stock |
| Galectin Therapeutics Inc | James C. Czirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 70,000 | 70,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | James C. Czirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 40,000 | 40,000 | - | - | Stock option (right to buy) |